Anti-MUC1 monoclonal antibody (OncoQuest)

N/A

Report date: 2023/08/22 10:15:19

Base Information

Drug NameAnti-MUC1 monoclonal antibody (OncoQuest)
Drug Alias NameBrevaRexAnti-MUC1 AR20.5AR20.5mAb-AR20.5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murine
Mechanisms of ActionMucin-1 inhibitors
TargetsMucin-1
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAltarex
China Registration ClassN/A

Develop Information

Active CompaniesAltarexVirexx Medical CorpOncoquest Inc
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A